127
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4

, , , , , , & show all
Pages 523-533 | Published online: 04 May 2016

References

  • AliISiddiqueLRehmanLUPrevalence of HCV among the high risk groups in Khyber PakhtunkhwaVirol J2011829621663685
  • AshfaqUAJavedTRehmanSNawazZRiazuddinSAn overview of HCV molecular biology, replication and immune responsesVirol J2011816121477382
  • AttaullahSKhanSAliIHepatitis C virus genotype in Pakistan: a systemic reviewVirol J2011843321902822
  • AverhoffFMGlassNHoltzmanDGlobal burden of hepatitis C: considerations for healthcare providers in the United StatesClin Infect Dis201255Suppl 1S101S105
  • HoofnagleJHCourse and outcome of hepatitis CHepatology200236S21S2912407573
  • RobinsonWSHepatitis B virus and hepatitis D virusMandelGLBennettJEDolinRPrinciples and Practice of Infectious Diseases5th edNew YorkChurchill Livingston200016521684
  • MottolaGCardinaliACeccacciCHepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic repliconsVirology2002293314311853397
  • ZhangCHXuGLJiaWDLiJSMaJLGeYSEffects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trialsInt J Cancer20111291254126421710498
  • LoguercioCFedericoAOxidative stress in viral and alcoholic hepatitisFree Radic Biol Med20033411012498974
  • Abd EllahMRThe role of liver biopsy in detection of hepatic oxidative stressVet Med Int20111417
  • OkudaMLiKBeardMRMitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core proteinGastroenterology200212236637511832451
  • HalliwellBThe wanderings of free radicalsFree Radic Biol Med20094653154219111608
  • TakagiHKakizakiSSoharaNPilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosisInt J Vitam Nutr Res20037341141514743544
  • WarisGAhsanHReactive oxygen species: role in the development of cancer and various chronic conditionsJ Carcinog200651416689993
  • PatelTApoptosis in hepatic pathophysiologyClin Liver Dis2000429531711232194
  • TsamandasACThomopoulosKGogosCExpression of bcl-2 oncoprotein in cases of acute and chronic viral hepatitis type B and type C: a clinicopathologic studyDig Dis Sci2002471618162412141825
  • FingasCDAltinbasASchlattjanMExpression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinomaDigestion20138717618123635474
  • RefaatBAshourTHEl-ShemiAGRibavirin induced anaemia: the effect of vitamin D supplementation on erythropoietin and erythrocyte indices in normal Wistar ratInt J Clin Exp Med201472667267625356124
  • HuangYWLiaoYTChenWVitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in TaiwanGenes Immun201011879319693091
  • Abu-MouchSFiremanZJarchovskyJZeinaARAssyNVitamin D supplement improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patientsWorld J Gastroenterol2011175184519022215943
  • PettaCCammàCScazzoneCLow vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis CHepatology2010511158116720162613
  • AtsukawaMTsubotaAShimadaNEfficacy of alfacalcidol on PEG-IFN/ribavirin combination therapy for elderly patients with chronic hepatitis C: a pilot studyHepat Mon201313e1487224403915
  • AtsukawaMTsubotaAShimadaNSerum 25(OH)D3 levels affect treatment outcomes for telaprevir/PEG-interferon/ribavirin combination therapy in genotype 1B chronic hepatitis CDig Liver Dis20144673874324880716
  • AtsukawaMTsubotaAShimadaNSerum 25-hydroxyvitamin D levels affect treatment outcome in PEGylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1B and high viral loadHepatol Res2014441277128524417888
  • LeeSSFerenciPOptimizing outcomes in patients with hepatitis C virus genotype 1 or 4Antivir Ther200813Suppl 191618432158
  • MuntanéJTargeting cell death and survival receptors in hepatocellular carcinomaAnticancer Agents Med Chem20111157658421554206
  • BluttSEMcDonnellTJPolekTCWeigelNLCalcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2Endocrinology2000141101710614618
  • KwonHJWonYSSuhHWVitamin D3 upregulated protein 1 suppresses TNF-α-induced NF-κB activation in hepatocarcinogenesisJ Immunol20101853980398920826751
  • DahlanYAtherHMAl-AhmadiMBatwaFAl-HamoudiWSustained virological response in a predominantly hepatitis C virus genotype 4 infected populationWorld J Gastroenterol2009154429443319764095
  • El HusseinyNMFahmyHMMohamedWAAminHHRelationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus EgyptiansWorld J Hepatol2012424224722993666
  • SchaalanMFMohamedWAAminHHVitamin D deficiency: correlation to interleukin-17, interleukin-23 and PIIINP in hepatitis C virus genotype 4World J Gastroenterol2012183738374422851868
  • NagpalSNaSRathnachalamRNoncalcemic actions of vitamin D receptor ligandsEndocr Rev20052666268715798098
  • PettaSGrimaudoSMarcoVDAssociation of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patientsJ Viral Hepat20132048649323730842
  • MohamedAASabryNAAbbassiMMIbrahimWAAli-EldinZAVitamin D levels in Egyptian HCV patients (genotype 4) treated with PEGylated interferonActa Gastroenterol Belg201376384423650781
  • AsahinaYTsuchiyaKTamakiNEffect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infectionHepatology20105251852720683951
  • IkedaKSaitohSAraseYEffect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysisHepatology1999291124113010094956
  • ZhangQCaoLYChengSJZhangAMJinXSLiYP53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIBOncol Rep2015331335134125591821
  • Abdel-HamidMEl-DalyMMolnegrenVGenetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinomaJ Gen Virol2007881526153117412982
  • AllamAGabrSAjaremJAbdel-MaksoudMBcl-2 and p53 expression in hepatic tissues of Egyptian patients with chronic hepatitis CJ Pak Med Assoc2015651186119226564290
  • KaziAMKhalidWQuestionnaire designing and validationJ Pak Med Assoc20126251451622755326
  • MatthewsDRHoskerJPRudenskiASNaylorBATreacherDFTurnerRCHomeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia1985284124193899825
  • AlghadirAHGabrSAAnwerSAl-EisaEFatigue and oxidative stress response to physical activity in type 2 diabetic patientsInt J Diabetes Dev Ctries2016365964
  • TsuchiyaMAsadaAKasaharaESmoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasmaCirculation20021051155115711889006
  • BedossaPIntraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis CHepatology19942015208020885
  • HolickMFVitamin D: evolutionary, physiological and health perspectivesCurr Drug Targets20111241820795941
  • FisherLFisherAVitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver diseaseClin Gastroenterol Hepatol2007551352017222588
  • HeaneyRPThe vitamin D requirement in health and diseaseJ Steroid Biochem Mol Biol200597131916026981
  • ThomopoulosKCArvanitiVTsamantasACPrevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosisEur J Gastroenterol Hepatol20061823323716462535
  • PoortahmasebiVAlavianSMKeyvaniHNorouziMMahmoodiMJazayeriSMHepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infectionAsian Pac J Cancer Prev2014153879388424935567
  • BaurKMertensJCSchmittJCombined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patientsLiver Int20123263564322151003
  • ArouchaDCdo CarmoRFMouraPHigh tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis CCytokine20136242142523602201
  • NeumanMGSchmilovitz-WeissHHilzenratNMarkers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis CInt J Hepatol2012201223121022530132
  • El RazikyMFathalahWFEl-AkelWAThe effect of peginterferon alpha-2a vs. peginterferon alpha-2b in treatment of naive chronic HCV genotype-4 patients: a single centre Egyptian studyHepat Mon201313e1006923922556
  • KnoblerHSchattnerATNF-α, chronic hepatitis C and diabetes: a novel triadQJM2005981615625348
  • EvansJLMadduxBAGoldfineIDThe molecular basis for oxidative stress-induced insulin resistanceAntioxid Redox Signal200571040105215998259
  • AwadMDShihaGESallamFAMohamedAEl TawabAEvaluation of liver stiffness measurement by fibroscan as compared to liver biopsy for assessment of hepatic fibrosis in children with chronic hepatitis CJ Egypt Soc Parasitol20134380581924640880
  • HolickMFVitamin D deficiencyN Engl J Med200735726628117634462
  • Pérez-LópezFRVitamin D and its implications for musculoskeletal health in women: an updateMaturitas20075811713717604580
  • LookerACMussolinoMESerum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adultsJ Bone Miner Res20082314315017907920
  • PeterlikMCrossHSVitamin D and calcium deficits predispose for multiple chronic diseasesEur J Clin Invest20053529030415860041
  • TrépoEOuzielRPradatPMarked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver diseaseJ Hepatol20135934435023557869
  • Putz-BankutiCPilzSStojakovicTAssociation of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver diseaseLiver Int20123284585122222013
  • GerovaDIGalunskaBTIvanovaIIPrevalence of vitamin D deficiency and insufficiency in Bulgarian patients with chronic hepatitis C viral infectionScand J Clin Lab Invest20147466567225005344
  • MalhamMJørgensenSPOttPVitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiologyWorld J Gastroenterol20111792292521412501
  • BarchettaICarottiSLabbadiaGLiver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virusHepatology2012562180218722753133
  • YamamotoNHommaSVitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytesProc Natl Acad Sci U S A199188853985431924312
  • WhitePCookeNThe multifunctional properties and characteristics of vitamin D-binding proteinTrends Endocrinol Metab20001132032710996527
  • MasudaSOkanoTOsawaKShinjoMSuematsuTKobayashiTConcentrations of vitamin D-binding protein and vitamin D metabolites in plasma of patients with liver cirrhosisJ Nutr Sci Vitaminol (Tokyo)1989352252342585144
  • García-ÁlvarezMPineda-TenorDJiménez-SousaMAFernández-RodríguezAGuzmán-FulgencioMResinoSRelationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysisHepatology2014601541155024975775
  • AfzalSBrøndum-JacobsenPBojesenSENordestgaardBGVitamin D concentration, obesity, and risk of diabetes: a Mendelian randomisation studyLancet Diabetes Endocrinol2014229830624703048
  • LiuEMeigsJBPittasAGPlasma 25 hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adultsJ Nutr200913932933419106328
  • LimJSMietus-SnyderMValenteASchwarzJMLustigRHThe role of fructose in the pathogenesis of NAFLD and the metabolic syndromeNat Rev Gastroenterol Hepatol2010725126420368739
  • GoldnerWSStonerJAThompsonJPrevalence of vitamin D insufficiency and deficiency in morbidly obese patients: a comparison with non-obese controlsObes Surg20081814515018175194
  • WeintraubSJFleckensteinJFMarionTNMadeyMAMahmoudiTMSchechtmanKBVitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment responseAm J Clin Nutr2012961025103123015322
  • DasarathyJPeriyalwarPAllampatiSHypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver diseaseLiver Int201434e118e12724118743
  • TargherGBertoliniLScalaLAssociations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver diseaseNutr Metab Cardiovasc Dis20071751752416928437
  • GrassoAMalfattiFDe LeoPInsulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirinJ Hepatol20095198499019695729
  • AlvarezJAAshrafARole of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasisInt J Endocrinol2010201035138520011094
  • YinYYuZXiaMLuoXLuXLingWVitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolismEur J Clin Invest2012421189119622958216
  • BilzerMRoggelFGerbesALRole of Kupffer cells in host defense and liver diseaseLiver Int2006261175118617105582
  • Gascon-BarréMDemersCMirshahiANéronSZalzalSNanciAThe normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cellsHepatology2003371034104212717384
  • AdamsJSHewisonMUnexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunityNat Clin Pract Endocrinol Metab20084809018212810
  • NgTIMoHPilot-MatiasTIdentification of host genes involved in hepatitis C virus replication by small interfering RNA technologyHepatology2007451413142117518369
  • MoustafaAHAliEMMohamedTMAbdouHIOxidative stress and thyroid hormones in patients with liver diseasesEur J Intern Med20092070370819818291
  • ParolaMRobinoGOxidative stress related molecules and liver fibrosisJ Hepatol20013529730611580156
  • GabrSAAlghadirAHPrediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkersIndian J Virol20142591100
  • OsmanHGGabrOMLotfySGabrSSerum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitisIndian J Med Microbiol20072532332918087079
  • LangeCMBibertSKutalikZA genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis CPLoS One20127e4015922808108
  • BellecavePSarasin-FilipowiczMDonzéOCleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon systemHepatology2010511127113620044805
  • ClarkPJThompsonAJVockDMHepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific mannerHepatology201256495622318926
  • ThompsonCBApoptosis in the pathogenesis and treatment of diseaseScience1995267145614627878464
  • FischerRBaumertTBlumHHepatitis C virus infection and apoptosisWorld J Gastroenterol2007134865487217828818
  • ValvaPDe MatteoEGaloppoMCGismondiMIPreciadoMVApoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosisJ Med Virol20108294995720419808
  • ZuckermanEZuckermanTSaharDBcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infectionBr J Haematol200111236436911167830
  • LapinskiTWPanasiukAJaroszewiczJKowalczukOFlisiakRRogalskaMSpecific ssDNA concentration in liver tissue as an index of apoptosis in hepatitis C virus-infected patientsWorld J Gastroenterol2005116130613316273639
  • HahnCSChoYGKangBSLesterIMHahnYSThe HCV core protein acts as a positive regulator of Fas-mediated apoptosis in a human lymphoblastoid T cell lineVirology200027612713711022001
  • ZhuNWareCFLaiMMHepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptorVirology200128317818711336543
  • ToyodaMKakizakiSHoriguchiNRole of serum soluble Fas/soluble Fas ligand and TNF-α on response to interferon-α therapy in chronic hepatitis CLiver20002030531110959809
  • CaponeFCostantiniSGuerrieroESerum cytokine levels in patients with hepatocellular carcinomaEur Cytokine Netw2010219910420478763
  • PiankoSPatellaSOstapowiczGDesmondPSievertWFas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infectionJ Viral Hepat2001840641311703571
  • Di MartinoVBrenotCSamuelDInfluence of liver hepatitis C virus RNA and hepatitis C virus genotype on Fas-mediated apoptosis after liver transplantation for hepatitis CTransplantation2000701390139611087158
  • ZhuLKongMHanYPSpontaneous liver fibrosis induced by long term dietary vitamin D deficiency in adult mice is related to chronic inflammation and enhanced apoptosisCan J Physiol Pharmacol20159338539425894394
  • SchnellGTripathiRBeyerJHepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavirAntimicrob Agents Chemother2015596807681526282418
  • GowerEEstesCBlachSRazavi-ShearerKRazaviHGlobal epidemiology and genotype distribution of the hepatitis C virus infectionJ Hepatol201461S45S5725086286
  • KamalSMImproving outcome in patients with hepatitis C virus genotype 4Am J Gastroenterol20071022582258817900328
  • KamalSMNasserIAHepatitis C genotype 4: what we know and what we don’t yet knowHepatology2008471371138318240152